Back to results
US 12,599,589 B2Granted
Prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome
AssigneeNippon Shinyaku Co., Ltd.
InventorsKen Okamoto, Maki Kurita, Hiroshi Yamaguchi
Life of this patent
Estimating the term…
Abstract
The present invention relates to a prophylactic and/or therapeutic agent for chronic prostatitis/chronic pelvic pain syndrome, the agent containing an mPGES-1 inhibitor as an active ingredient.
Claims3
A method for treating chronic prostatitis/chronic pelvic pain syndrome, the method comprising administering an mPGES-1 inhibitor to a subject in need thereof,
- wherein the mPGES-1 inhibitor is at least one compound selected from the group consisting of:
- N-(3-chloro-2-methylphenyl)-2-(methoxymethyl)-6-({[2-(trifluoromethyl)phenyl]carbonyl}amino)-1H-benzimidazole-4-carboxamide, and
- N-(3-chloro-2-methylphenyl)-2-[1-(trifluoromethyl)cyclopropyl]-6-({[2-(trifluoromethyl)phenyl]carbonyl}amino)-1H-benzimidazole-4-carboxamide, or a tautomer of the compound, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.